Cryoport, Inc. (NASDAQ:CYRX) Stock Holdings Lowered by GW&K Investment Management LLC

GW&K Investment Management LLC lowered its position in shares of Cryoport, Inc. (NASDAQ:CYRXGet Rating) by 0.6% during the fourth quarter, Holdings Channel reports. The fund owned 771,317 shares of the consumer goods maker’s stock after selling 4,910 shares during the quarter. GW&K Investment Management LLC’s holdings in Cryoport were worth $45,639,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its holdings in shares of Cryoport by 1.8% during the fourth quarter. Geode Capital Management LLC now owns 764,252 shares of the consumer goods maker’s stock valued at $45,220,000 after acquiring an additional 13,574 shares during the period. Renaissance Technologies LLC acquired a new stake in shares of Cryoport during the fourth quarter valued at approximately $1,337,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Cryoport by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 315,642 shares of the consumer goods maker’s stock valued at $18,677,000 after acquiring an additional 7,410 shares during the period. Ensign Peak Advisors Inc acquired a new stake in shares of Cryoport during the fourth quarter valued at approximately $355,000. Finally, Allianz Asset Management GmbH raised its holdings in shares of Cryoport by 72.6% during the fourth quarter. Allianz Asset Management GmbH now owns 8,024 shares of the consumer goods maker’s stock valued at $475,000 after acquiring an additional 3,374 shares during the period.

A number of equities research analysts have recently issued reports on the stock. SVB Leerink boosted their price target on shares of Cryoport from $75.00 to $92.00 and gave the company an “outperform” rating in a report on Friday, February 25th. TheStreet lowered shares of Cryoport from a “c-” rating to a “d+” rating in a research note on Friday, January 28th. B. Riley dropped their price objective on shares of Cryoport from $61.00 to $55.00 in a research note on Tuesday. Needham & Company LLC reiterated a “buy” rating and issued a $45.00 price objective on shares of Cryoport in a research note on Wednesday, April 13th. Finally, KeyCorp dropped their price objective on shares of Cryoport from $92.00 to $52.00 in a research note on Friday, May 6th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $59.00.

In related news, CEO Jerrell Shelton sold 3,298 shares of the company’s stock in a transaction on Wednesday, March 9th. The shares were sold at an average price of $31.05, for a total transaction of $102,402.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mark W. Sawicki sold 1,410 shares of the company’s stock in a transaction on Wednesday, March 9th. The stock was sold at an average price of $31.05, for a total transaction of $43,780.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,803 shares of company stock valued at $180,183. 9.70% of the stock is owned by insiders.

CYRX stock traded up $0.01 during trading hours on Friday, hitting $23.27. The company’s stock had a trading volume of 409,618 shares, compared to its average volume of 665,178. The company has a quick ratio of 14.48, a current ratio of 14.98 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $1.15 billion, a PE ratio of -3.81 and a beta of 1.30. Cryoport, Inc. has a 12 month low of $19.82 and a 12 month high of $86.30. The stock has a 50 day moving average price of $28.58 and a two-hundred day moving average price of $43.91.

Cryoport (NASDAQ:CYRXGet Rating) last posted its earnings results on Thursday, May 5th. The consumer goods maker reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.18) by ($0.13). The business had revenue of $52.30 million during the quarter, compared to the consensus estimate of $52.86 million. Cryoport had a negative return on equity of 13.79% and a negative net margin of 128.78%. The business’s revenue was down 1.9% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.13) earnings per share. Sell-side analysts expect that Cryoport, Inc. will post -0.66 earnings per share for the current year.

Cryoport Profile (Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

Further Reading

Want to see what other hedge funds are holding CYRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cryoport, Inc. (NASDAQ:CYRXGet Rating).

Institutional Ownership by Quarter for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.